Host-Pathogen Interactions Operative during Mycobacteroides abscessus Infection

키워드

참고문헌 (115)

1. Johansen MD, "Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus", Nat Rev Microbiol, 18, pp.392~407 (2020)
2. Victoria L, "Mycobacterium abscessus complex : a review of recent developments in an emerging pathogen", Front Cell Infect Microbiol, 11, pp.659997~ (2021)
3. Minias A, "Subspecies-specific sequence detection for differentiation of Mycobacterium abscessus complex", Sci Rep, 10, pp.16415~ (2020)
4. Tortoli E, "Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. nov", Int J Syst Evol Microbiol, 66, pp.4471~4479 (2016)
5. Schiff HF, "Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens : seven year experience in a UK hospital", Sci Rep, 9, pp.1730~ (2019)
6. Flight WG, "Outcomes of pulmonary Mycobacterium abscessus infection", Int J Mycobacteriol, 9, pp.48~52 (2020)
7. Medjahed H, "Mycobacterium abscessus : a new player in the mycobacterial field", Trends Microbiol, 18, pp.117~123 (2010)
8. Degiacomi G, "Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients", Int J Mol Sci, 20, pp.5868~ (2019)
9. Ho D, "High prevalence of nontuberculous mycobacteria in cystic fibrosis patients in tropical French Reunion Island", Pediatr Infect Dis J, 40, pp.e120~e122 (2021)
10. Leung JM, "Nontuberculous mycobacteria : the changing epidemiology and treatment challenges in cystic fibrosis", Curr Opin Pulm Med, 19, pp.662~669 (2013)
11. Bastian S, "Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41)and rrl sequencing", Antimicrob Agents Chemother, 55, pp.775~781 (2011)
12. Honda JR, "Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections", Curr Opin Immunol, 54, pp.66~73 (2018)
13. Adjemian J, "Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA", Emerg Infect Dis, 23, pp.439~447 (2017)
14. Crilly NP, "The new frontier of host-directed therapies for Mycobacterium avium complex", Front Immunol, 11, pp.623119~ (2021)
15. Lee MR, "Mycobacterium abscessus complex infections in humans", Emerg Infect Dis, 21, pp.1638~1646 (2015)
16. Berube BJ, "Novel screen to assess bactericidal activity of compounds against non-replicating Mycobacterium abscessus", Front Microbiol, 9, pp.2417~ (2018)
17. Fangous MS, "Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry", J Clin Microbiol, 52, pp.3362~3369 (2014)
18. To K, "General overview of nontuberculous mycobacteria opportunistic pathogens : Mycobacterium avium and Mycobacterium abscessus", J Clin Med, 9, pp.2541~ (2020)
19. Griffin I, "Outbreak of tattoo-associated nontuberculous mycobacterial skin infections", Clin Infect Dis, 69, pp.949~955 (2019)
20. Lee H, "Mortality and prognostic factors of nontuberculous mycobacterial infection in Korea : a population-based comparative study", Clin Infect Dis, 72, pp.e610~e619 (2021)
21. Kothavade RJ, "Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria", Eur J Clin Microbiol Infect Dis, 32, pp.161~188 (2013)
22. Renna M, "Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection", J Clin Invest, 121, pp.3554~3563 (2011)
23. Kim HY, "Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene(erm)and clarithromycin susceptibility patterns", Microbiol Immunol, 54, pp.347~353 (2010)
24. Choi GE, "Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance", Am J Respir Crit Care Med, 186, pp.917~925 (2012)
25. Gloag ES, "Mycobacterium abscessus biofilms have viscoelastic properties which may contribute to their recalcitrance in chronic pulmonary infections", Sci Rep, 11, pp.5020~ (2021)
26. Bryant JM, "Stepwise pathogenic evolution of Mycobacterium abscessus", Science, 372, pp.eabb8699~ (2021)
27. Bryant JM, "Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium", Science, 354, pp.751~757 (2016)
28. Yoon JK, "Whole genome sequencing of nontuberculous mycobacterium(NTM)isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment", BMC Genomics, 21, pp.322~ (2020)
29. Caverly LJ, "Mycobacterium abscessus morphotype comparison in a murine model", PLoS One, 10, pp.e0117657~ (2015)
30. Roux AL, "The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages", Open Biol, 6, pp.160185~ (2016)
31. Whang J, "Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D", Cell Death Dis, 8, pp.e3012~ (2017)
32. 김진경, "Host-Pathogen Dialogues in Autophagy, Apoptosis, and Necrosis during Mycobacterial Infection", Immune Network, 20(5), pp.1~15 (2020), 대한면역학회[DOI]
33. Honda JR, "Nontuberculous mycobacteria show differential infectivity and use phospholipids to antagonize LL-37", Am J Respir Cell Mol Biol, 62, pp.354~363 (2020)
34. Yuk JM, "Vitamin D3 induces autophagy in human monocytes", macrophages via cathelicidin, 2009, pp.6, 231~243
35. Dumas E, "Mycobacterial pan-genome analysis suggests important role of plasmids in the radiation of Type VII secretion systems", Genome Biol Evol, 8, pp.387~402 (2016)
36. Abdallah AM, "Type VII secretion--mycobacteria show the way", Nat Rev Microbiol, 5, pp.883~891 (2007)
37. Newton-Foot M, "The plasmid-mediated evolution of the mycobacterial ESX(Type VII)secretion systems", BMC Evol Biol, 16, pp.62~ (2016)
38. Gey van Pittius NC, "Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6(esx)gene cluster regions", BMC Evol Biol, 6, pp.95~ (2006)
39. Cole ST, "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence", Nature, 393, pp.537~544 (1998)
40. Kim YS, "Mycobacterium abscessus ESX-3 plays an important role in host inflammatory and pathological responses during infection", Microbes Infect, 19, pp.5~17 (2017)
41. Laencina L, "Identification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus", Proc Natl Acad Sci U S A, 115, pp.E1002~E1011 (2018)
42. Melly G, "MmpL proteins in physiology and pathogenesis of M. tuberculosis", Microorganisms, 7, pp.70~ (2019)
43. Dubois V, "MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family", Proc Natl Acad Sci U S A, 115, pp.E10147~E10156 (2018)
44. Bakala N’Goma JC, "Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice", Infect Immun, 83, pp.780~791 (2015)
45. Becker K, "Lipoprotein glycosylation by protein-o-mannosyltransferase(MAB_1122c)contributes to low cell envelope permeability and antibiotic resistance of Mycobacterium abscessus", Front Microbiol, 8, pp.2123~ (2017)
46. 이승준, "Mycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity", BMB Reports, 49(10), pp.554~559 (2016), 생화학분자생물학회
47. Le Moigne V, "MgtC as a host-induced factor and vaccine candidate against Mycobacterium abscessus infection", Infect Immun, 84, pp.2895~2903 (2016)
48. Halloum I, "Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent", Proc Natl Acad Sci U S A, 113, pp.E4228~E4237 (2016)
49. Kilinç G, "Host-directed therapy to combat mycobacterial infections", Immunol Rev, 301, pp.62~83 (2021)
50. Prasla Z, "Macrophage signaling pathways in pulmonary nontuberculous mycobacteria infections", Am J Respir Cell Mol Biol, 63, pp.144~151 (2020)
51. Kawai T, "Toll-like receptors and their crosstalk with other innate receptors in infection and immunity", Immunity, 34, pp.637~650 (2011)
52. Dolasia K, "TLRs", NLRs : Shaping the landscape of host immunity, 2018, pp.37, 3~19
53. Feng H, "Interferon regulatory factor 1(IRF1)and anti-pathogen innate immune responses", PLoS Pathog, 17, pp.e1009220~ (2021)
54. Tak PP, "NF-kappaB : a key role in inflammatory diseases", J Clin Invest, 107, pp.7~11 (2001)
55. Kim BR, "Mycobacterium abscessus infection leads to enhanced production of type 1 interferon and NLRP3 inflammasome activation in murine macrophages via mitochondrial oxidative stress", PLoS Pathog, 16, pp.e1008294~ (2020)
56. Feng Z, "Differential responses by human macrophages to infection with Mycobacterium tuberculosis and non-tuberculous mycobacteria", Front Microbiol, 11, pp.116~ (2020)
57. Swanson KV, "The NLRP3 inflammasome : molecular activation and regulation to therapeutics", Nat Rev Immunol, 19, pp.477~489 (2019)
58. Paik S, "An update on the regulatory mechanisms of NLRP3 inflammasome activation", Cell Mol Immunol, 18, pp.1141~1160 (2021)
59. Lee HM, "Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62", SQSTM1, 2012, pp.90, 601~610
60. Le Moigne V, "TLR2-activating fraction from Mycobacterium abscessus rough variant demonstrates vaccine and diagnostic potential", Front Cell Infect Microbiol, 10, pp.432~ (2020)
61. Kim JS, "Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus", Infect Immun, 83, pp.1556~1567 (2015)
62. Davidson LB, "Mycobacterium abscessus glycopeptidolipid prevents respiratory epithelial TLR2 signaling as measured by HβD2 gene expression and IL-8 release", PLoS One, 6, pp.e29148~ (2011)
63. Ruangkiattikul N, "Type I interferon induced by TLR2-TLR4-MyD88-TRIF-IRF3 controls Mycobacterium abscessus subsp. abscessus persistence in murine macrophages via nitric oxide", Int J Med Microbiol, 309, pp.307~318 (2019)
64. Kim TS, "Mycobacterium massiliense induces inflammatory responses in macrophages through Toll-like receptor 2 and c-Jun N-terminal kinase", J Clin Immunol, 34, pp.212~223 (2014)
65. Lee JY, "Nucleotide-binding oligomerization domain 2 contributes to limiting growth of Mycobacterium abscessus in the lung of mice by regulating cytokines and nitric oxide production", Front Immunol, 8, pp.1477~ (2017)
66. Jang MA, "Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis", J Hum Genet, 58, pp.298~303 (2013)
67. Bernut A, "CFTR protects against Mycobacterium abscessus infection by fine-tuning host oxidative defenses", Cell Rep, 26, pp.1828~1840.e4 (2019)
68. Johansen MD, "CFTR depletion confers hypersusceptibility to Mycobacterium fortuitum in a zebrafish model", Front Cell Infect Microbiol, 10, pp.357~ (2020)
69. Künzi L, "Cystic fibrosis lung disease in the aging population", Front Pharmacol, 12, pp.601438~ (2021)
70. Mall MA, "Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease", Ann Am Thorac Soc, 13(Suppl 2), pp.S177~S185 (2016)
71. Hoyos-Bachiloglu R, "A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations", J Clin Invest, 127, pp.4415~4420 (2017)
72. Shu CC, "Mono-and poly-functional T cells in nontuberculous mycobacteria lung disease patients : implications in analyzing risk of disease progression", Cytokine, 120, pp.176~185 (2019)
73. Kim SY, "Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease", PLoS One, 9, pp.e109941~ (2014)
74. Quan H, "Human cytomegalovirus-induced interleukin-10 production promotes the proliferation of Mycobacterium massiliense in macrophages", Front Immunol, 11, pp.518605~ (2020)
75. Zhang C, "Mycobacterium abscessus-bronchial epithelial cells cross-talk through type I interferon Signaling", Front Immunol, 10, pp.2888~ (2019)
76. Bernut A, "Mycobacterium abscessus-induced granuloma formation is strictly dependent on TNF signaling and neutrophil trafficking", PLoS Pathog, 12, pp.e1005986~ (2016)
77. Brode SK, "Increased risk of mycobacterial infections associated with anti-rheumatic medications", Thorax, 70, pp.677~682 (2015)
78. Kim YJ, "Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis", Virulence, 11, pp.1225~1239 (2020)
79. Paik S, "Autophagy : a new strategy for host-directed therapy of tuberculosis", Virulence, 10, pp.448~459 (2019)
80. Deretic V, "Autophagy in inflammation, infection, and immunometabolism", Immunity, 54, pp.437~453 (2021)
81. Rao L, "Autophagy in pulmonary innate immunity", J Innate Immun, 12, pp.21~30 (2020)
82. Yi Sak Kim, "Autophagy-activating strategies to promote innate defense against mycobacteria", Experimental and Molecular Medicine, 51, pp.1~10 (2019), 생화학분자생물학회[DOI]
83. Riebisch AK, "Autophagy-A story of bacteria interfering with the host cell degradation machinery", Pathogens, 10, pp.110~ (2021)
84. Chauhan S, "TRIMs and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis", Dev Cell, 39, pp.13~27 (2016)
85. Chai Q, "A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy", Nat Commun, 10, pp.1973~ (2019)
86. Watson RO, "The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy", Cell Host Microbe, 17, pp.811~819 (2015)
87. Martinez J, "Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins", Nat Cell Biol, 17, pp.893~906 (2015)
88. Silwal P, "Autophagy and host defense in nontuberculous mycobacterial infection", Front Immunol, 12, pp.728742~ (2021)
89. Shamaei M, "Nontuberculous mycobacteria, macrophages, and host innate immune response", Infect Immun, 89, pp.e0081220~ (2021)
90. Zullo AJ, "Mycobacterial induction of autophagy varies by species and occurs independently of mammalian target of rapamycin inhibition", J Biol Chem, 287, pp.12668~12678 (2012)
91. Zullo AJ, "Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages", BMC Biochem, 15, pp.4~ (2014)
92. Pohl K, "Mycobacterium abscessus clearance by neutrophils is independent of autophagy", Infect Immun, 88, pp.e00024-20~ (2020)
93. Sohn H, "High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease", Microb Pathog, 47, pp.321~328 (2009)
94. Kim SW, "Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages", Pathog Dis, 75, pp.ftx107~ (2017)
95. Junkins RD, "The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections", Autophagy, 10, pp.538~547 (2014)
96. Gaudino SJ, "Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis", Front Immunol, 10, pp.360~ (2019)
97. Munroe ME, "A costimulatory function for T cell CD40", J Immunol, 178, pp.671~682 (2007)
98. Philips EA, "Structural, functional, and evolutionary differences between PD-L1 and PD-L2", J Immunol, 200 (2018)
99. Wu UI, "Patients with idiopathic pulmonary nontuberculous mycobacterial disease have normal Th1", Th2 cytokine responses but diminished Th17 cytokine and enhanced granulocyte-macrophage colony-stimulating factor production, 2019, pp.6, ofz484~
100. Lim A, "Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency", Clin Immunol, 137, pp.296~302 (2010)
101. Abate G, "BCG vaccination induces M. avium and M. abscessus cross-protective immunity", Front Immunol, 10, pp.234~ (2019)
102. Shu CC, "The clinical significance of programmed death-1, regulatory T cells and myeloid derived suppressor cells in patients with nontuberculous mycobacteria-lung disease", J Clin Med, 8, pp.736~ (2019)
103. Gibson RL, "Pathophysiology and management of pulmonary infections in cystic fibrosis", Am J Respir Crit Care Med, 168, pp.918~951 (2003)
104. Monin L, "Aspergillus fumigatus preexposure worsens pathology and improves control of Mycobacterium abscessus pulmonary infection in mice", Infect Immun, 86, pp.e00859-17~ (2018)
105. Lutzky VP, "Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection", Front Immunol, 9, pp.1319~ (2018)
106. Storder J, "Update on the role of Sirtuin 3 in cell differentiation : a major metabolic target that can be pharmacologically controlled", Biochem Pharmacol, 169, pp.113621~ (2019)
107. Marcus JM, "SIRT3 regulation under cellular stress : making sense of the ups and downs", Front Neurosci, 12, pp.799~ (2018)
108. Mirza AZ, "Role of PPAR receptor in different diseases and their ligands : physiological importance and clinical implications", Eur J Med Chem, 166, pp.502~513 (2019)
109. Kim YS, "The peroxisome proliferator-activated receptor alpha-agonist gemfibrozil promotes defense against Mycobacterium abscessus infections", Cells, 9, pp.648~ (2020)
110. Gonzalez-Mancera MS, "STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection", Respir Med Case Rep, 30, pp.101125~ (2020)
111. Wang X, "HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization", J Cell Mol Med, 23, pp.7985~7998 (2019)
112. O'Neill LA, "MicroRNAs : the fine-tuners of Toll-like receptor signalling", Nat Rev Immunol, 11, pp.163~175 (2011)
113. Silwal P, "The roles of microRNAs in regulation of autophagy during bacterial infection", Semin Cell Dev Bio, 101, pp.51~58 (2020)
114. Kim Hyeon Ji, "MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus", Experimental and Molecular Medicine, 53, pp.1~14 (2021), 생화학분자생물학회[DOI]
115. Han SA, "miRNA expression profiles and potential as biomarkers in nontuberculous mycobacterial pulmonary disease", Sci Rep, 10, pp.3178~ (2020)

관련 논문AI추천